Response to comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
El-Zein
Randa A
RA
Hay
Matthew J
MJ
Lopez
Mirtha S
MS
Bondy
Melissa L
ML
Morris
Debra L
DL
Legator
Marvin S
MS
Abdel-Rahman
Sherif Z
SZ
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002273:Carcinogens; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002869:Chromosome Aberrations / Q000139:chemically induced*; D004249:DNA Damage; D023381:Endpoint Determination; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects* / Q000627:therapeutic use; D009152:Mutagenicity Tests; D009153:Mutagens; D009369:Neoplasms / Q000139:chemically induced; D015203:Reproducibility of Results; D012107:Research Design; D012307:Risk Factors
D002273:Carcinogens; D000697:Central Nervous System Stimulants; D009153:Mutagens; D008774:Methylphenidate